tazobactam has been researched along with Infectious Skin Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cullmann, W; Elhardt, D; Tassler, H | 1 |
| Wise, R | 1 |
| Christou, N; Eiseman, I; Siami, G; Tack, KJ | 1 |
2 trial(s) available for tazobactam and Infectious Skin Diseases
| Article | Year |
|---|---|
The efficacy and safety of piperacillin/tazobactam in the therapy of bacteraemia.
Topics: Abdomen; Adult; Bacteremia; beta-Lactamase Inhibitors; Drug Therapy, Combination; Female; Humans; Male; Neutropenia; Penicillanic Acid; Piperacillin; Respiratory Tract Infections; Skin Diseases, Infectious; Tazobactam | 1993 |
Clinafloxacin versus piperacillin-tazobactam in treatment of patients with severe skin and soft tissue infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bacterial Infections; beta-Lactamase Inhibitors; Drug Therapy, Combination; Enzyme Inhibitors; Female; Fluoroquinolones; Humans; Male; Middle Aged; Penicillanic Acid; Penicillins; Piperacillin; Skin Diseases, Infectious; Tazobactam | 2001 |
1 other study(ies) available for tazobactam and Infectious Skin Diseases
| Article | Year |
|---|---|
Therapy of soft tissue infections with piperacillin/tazobactam.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Piperacillin; Risk Factors; Skin Diseases, Infectious; Tazobactam | 1993 |